Word

WUXI TIDES

Status

Pending

Status Code

688

Status Date

Tuesday, May 7, 2024

Serial Number

97775103

Mark Type

4

Filing Date

Tuesday, January 31, 2023

Published for Opposition

Tuesday, March 12, 2024

Trademark Owner History

Shanghai SynTheAll Pharmaceutical Co., Ltd - Owner At Publication

Classifications

9 Recorded computer operating programs; Computer programs recorded on data media in the nature of computer software designed for use in creating searchable databases of information and data for use in the field of pharmaceutical research; Computer programs recorded on data media in the nature of computer software designed for use in database management for use in the field of information technology; Computer programs recorded on data media in the nature of software designed for organizing and viewing digital images for use in the field of cloud computing; Data processing apparatus; Encoded magnetic identifying cards; Intercommunication apparatus, namely, virtual machine server login device in the nature of computers; Intercommunication apparatus for voice and data transmission, namely, telephones; Intercommunication apparatus for remote access to data, namely, computers; Intercommunication apparatus, namely, apparatus in the nature of computers for transmission of communication; Laboratory trays; Test tubes; Petri dishes; Downloadable computer software platforms for application development and database management; Recorded computer software platforms for application development and database management; Laboratory robot; Laboratory equipment for detecting gene sequences, namely, centrifuge tubes; Glassware for laboratory scientific test purposes; Laboratory instruments in the nature of laboratory swabs for testing pathogens and toxins in biological samples, for researching purposes; Electronic apparatus for testing the sterility of medical equipment; Electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; Laboratory apparatus and instruments, namely, pre-packed columns for use in chemical synthesis; Laboratory chemical reactors; Reactors, coils, retorts and crackers for use in high temperature chemical reactions; Instrument and measuring apparatus for physico-chemical experiment and composition analysis, namely, centrifuge tubes; Surveying apparatus; Surveying instruments

5 Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Medicines for human purposes, namely, medicines for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Raw material medicine, namely, medicines for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Pharmaceutical preparations, for the treatment of cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; pharmaceutical preparations, namely, antivirals; Chemico-pharmaceutical preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Biological preparations for medical purposes for the treatment of cancer; Chemical preparations for the diagnosis of pregnancy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders healthcare and clinical applications; Chemical preparations for medical purposes, namely, chemical reagents for medical purposes; Chemical preparations for medical purposes for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Diagnostic preparations for medical purposes; Nutritional supplements; Drugs for medical purposes for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Reagent paper for medical purposes; Medical reagent; Disinfectants for hygiene purposes; Cultures of microorganisms for medical use; Biomedicines for the treatment of cancer, cardiovascular, hematologic, neurological,; gastrointestinal and genetic diseases; Adjuvants for medical purposes; Vaccines; Veterinary preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases

38 Message sending and receiving services; Electronic message sending; Transmission of sound, video and information; Transmission of sound, video and information, namely, television broadcasting; Providing an online forum for the transmission of information between computer users; Transmission of digital files; Providing access to databases; Electronic transmission of data and documents through computer terminals; Computer aided transmission of messages and images; Electronic data transmission; Transmission of information through a digital network

35 Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; Retrieving data from computer files for others, namely, electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Providing business information via a website; Import and export agencies; Provision of an on-line marketplace for buyers and sellers of goods and services; Advertising services; Personnel management consultancy; business administrative services for the relocation of businesses; Accounting services; Sponsorship search; Compilation of information into computer databases; Wholesale services through direct solicitation by distributors directed to end-users featuring medical instruments; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store and retail store services featuring medicines; Provide business consulting for enterprises; Collection of market research information; Business management consultancy, namely, personnel management consultancy; Computerized market research service; Updating and maintenance of data in computer databases; Systemization of information into computer databases; Presentation of goods on communication media, for retail purposes, namely, providing television home shopping services in the field of general consumer merchandise; Providing business enterprise information and business information through global computer network; Business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Market study and analysis of market studies; Business management assistance, namely, accounting services; Commercial information and advice for consumers in the choice of products and services; Public relations consultancy; Arrangement and organization of marketing promotion for others; Marketing services

42 Computer programming; Material testing; Technical research in the field of pharmaceutical studies; Research and development of new products for others; Technology consultancy in the field of cybersecurity; Chemical analysis; Chemistry services, namely, chemistry consultation; Chemical research; Biological research; conducting clinical trials for others, being for scientific and medical research; Quality checking and testing, namely, quality control for others; Scientific laboratory services; Genome structure and function analysis; Gene screening, namely, DNA screening for scientific research purpose; Biomedical research services; Stem cell research service; Drug research and development services, namely, pharmaceutical research; cell culture services for scientific research purposes, for others; Design and development of computer hardware and software; Development and creation of computer programs for data processing; Computer programming in the field of medical treatment; Product quality testing; assessment of quality of products; Scientific research; Surveying; Bacteriological research; The design, production in the nature of design, or maintenance of a computer program; Computer software design; Computer technology consultancy in the field of engineering; Information technology consulting relating to computer network design; Artificial intelligence technology consulting; Research on artificial intelligence technology; Research and development of new products; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Drug evaluation, namely, pharmaceutical product evaluation; Vaccine research and development services; Cancer medicine research; Biotechnology research; Drug testing being testing of pharmaceuticals; Pharmaceutical research; Cancer scientific research for medical purposes; Development and Test of Chemical production methods; Implementing of early evaluation in the field of new drugs, namely, product quality testing; Biochemical research and analysis; Chemical analysis evaluation service; Chemical synthesis evaluation service; scientific research of the mode of action of chemical combinations on animals

"WUXI"

Trademark Events

Feb 3, 2023

New Application Entered

Feb 3, 2023

Teas Voluntary Amendment Received

Feb 3, 2023

Teas Amendment Entered Before Attorney Assigned

Feb 18, 2023

New Application Office Supplied Data Entered

Oct 28, 2023

Assigned To Examiner

Nov 7, 2023

Non-Final Action Written

Nov 7, 2023

Non-Final Action E-Mailed

Nov 7, 2023

Notification Of Non-Final Action E-Mailed

Jan 5, 2024

Teas Change Of Owner Address Received

Jan 5, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

Jan 5, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jan 5, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Jan 5, 2024

Teas Change Of Domestic Representatives Address

Jan 5, 2024

Teas Change Of Correspondence Received

Jan 8, 2024

Teas Response To Office Action Received

Jan 8, 2024

Correspondence Received In Law Office

Jan 9, 2024

Teas/Email Correspondence Entered

Feb 5, 2024

Approved For Pub - Principal Register

Feb 21, 2024

Notification Of Notice Of Publication E-Mailed

Mar 12, 2024

Published For Opposition

Feb 21, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 12, 2024

Official Gazette Publication Confirmation E-Mailed

May 7, 2024

Noa E-Mailed - Sou Required From Applicant

Jul 4, 2024

Teas Statement Of Use Received